Skip to content

Ayurvedic management of Sthaulya with Triphaladighanavati and Vaman and Virechan Panchakarma.

â??Randomised Controlled Trial on Principles of Management of Sthaulya by Triphaladighanavati after Vamana Specifically on Body Mass Indexâ??

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/06/019883
Enrollment
70
Registered
2019-06-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E669- Obesity, unspecified

Interventions

Intervention1: Vaman followed by Triphaladighanavati: Rukshana Pachan Kvath 20 ml BD will be given to the Sthaulya patients for 5 Days then Snehapana by Triphaladi Tailpana as 30ml,45ml,60ml,75 ml,90m

Sponsors

Self Dr Sagar Gopal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients having clinical features of Sthaulya with respect to Ayurveda classics. 2)Patients of Sthaulya having BMI more than 25Kg/m2and less than 35Kg/m2. (Obese-1 & Obese- 2). 3)Patients of either sex aged between 18- 70 years irrespective of caste, religion, socio economic & educational status. 4)Those patients of Sthaulya who are willing to participate in trial and ready to give written consent will be included.

Exclusion criteria

Exclusion criteria: 1)Patients of obesity due to hypothyroidism, Cushingâ??s syndrome and obesity with any other systemic disorders like Ischemic heart disease will be excluded. 2)Patients of Sthaulya with hypertension and diabetes mellitus will be excluded. 3)Patients of drug induced obesity for example Hormonal replacement therapy, consumption of anabolic steroids etc. will be excluded. 4)Pregnant females & lactating mothers will not be considered. 5)Patients who are currently participating in other clinical trials (since last six months) will be excluded. 6)Those patients who are contra indicated for Vamana and Virechana.

Design outcomes

Primary

MeasureTime frame
Triphaladighanavati after Vamana have equal effect as that of Triphaladighanavati after Virechana in Sthaulya in reducing weight and Body Mass Index.Timepoint: 52 Days

Secondary

MeasureTime frame
1) To evaluate the effect of Vamana followed by Triphaladighanavati on insulin resistance (HOMA-IR) [16] and to compare its result with that of Virechana followed by Triphaladighanavati.Timepoint: 52 Days

Countries

India

Contacts

Public ContactDr Prakash Kabra

Government Ayurved College and hospital Nagpur

kabraprakash2711@gmail.com9225226567

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026